Ole Haagen Nielsen, MD, DMSc; Mark Andrew Ainsworth, MD, PhD, DMSc
Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-3060.
Corresponding Author: Ole Haagen Nielsen, MD, DMSc, Department of Gastroenterology, Herlev Hospital, Medical Section D112M, 75 Herlev Ringvej, DK-2730 Herlev, Denmark; e-mail, email@example.com.
Current Author Addresses: Dr. Nielsen: Department of Gastroenterology, Herlev Hospital, Medical Section D112M, 75 Herlev Ringvej, DK-2730 Herlev, Denmark.
Dr. Ainsworth: Department of Gastroenterology, Odense University Hospital, J.B. Winsløws Vej 4, DK-5000 Odense C, Denmark.
Nielsen OH, Ainsworth MA. Biosimilars for Management of Crohn Disease. Ann Intern Med. 2019;170:129–130. [Epub ahead of print 11 December 2018]. doi: 10.7326/M18-3060
Download citation file:
Published: Ann Intern Med. 2019;170(2):129-130.
Published at www.annals.org on 11 December 2018
Gastroenterology/Hepatology, Inflammatory Bowel Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use